Entering text into the input field will update the search result below
Try for free
Search for Symbols, analysts, keywords

Editas Medicine down 6%, prices $125M offering

  • A clinical-stage genome editing company- Editas Medicine (NASDAQ:EDIT) prices 12.5M shares at $10.00 per share.
  • Gross proceeds are expected to be ~$125M.
  • Underwriters have a 30-day option to purchase up to an additional 1.88M shares.
  • The offering is expected to close on or about June 20, 2023.
  • The stock price is down 6% during pre-market hours on Thursday.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.